|
Q3 2021
Filed on Nov 09, 2021
|
579,609
|
N/A
|
|
Alexion Pharmaceuticals Inc
|
Q3 2021
Filed on Nov 09, 2021
|
17,495,607
|
N/A
|
|
Dragoneer Growth Opportun CO
|
Q3 2021
Filed on Nov 09, 2021
|
189,998
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
333
|
$9.99 - $10.81
$3.33K - $3.6K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
6,163
|
$14.51 - $15.78
$89.4K - $97.3K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
1,976
|
N/A
|
|
Brookfield Property Partrs L
|
Q3 2021
Filed on Nov 09, 2021
|
4,863,308
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
1,488,244
|
N/A
|
|
Brookfield Asset Mgmt Reins
|
Q3 2021
Filed on Nov 09, 2021
|
481
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
241,097
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
3,461,963
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
1,400,100
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
1,398,800
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
900,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
861,400
|
N/A
|
|
Landcadia Holdings Iii Inc
|
Q3 2021
Filed on Nov 09, 2021
|
610
|
N/A
|
|
Dragoneer Growth Opportun CO
|
Q3 2021
Filed on Nov 09, 2021
|
443,471
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
2,303,983
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
520
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
7,757,179
|
N/A
|
|
European Sustainable Growth
|
Q3 2021
Filed on Nov 09, 2021
|
4,705
|
N/A
|
|
Apellis Pharmaceuticals Inc
|
Q3 2021
Filed on Nov 09, 2021
|
2,575,000
|
N/A
|
|
Maxim Integrated Prods Inc
|
Q3 2021
Filed on Nov 09, 2021
|
24,122,903
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
11,876
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
13,196
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
1,227,587
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
2,962,701
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
482
|
N/A
|
|
European Sustainable Growth
|
Q3 2021
Filed on Nov 09, 2021
|
10,245
|
N/A
|
|
Cerevel Therapeutics Hldng I
|
Q3 2021
Filed on Nov 09, 2021
|
236,914
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
3,687,416
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
1,500,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
236,017
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
77,606
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
32,574
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
10,301
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
6,191
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
553
|
$5.33 - $6.45
$2.95K - $3.57K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
184,891
|
N/A
|
|
Intercept Pharmaceuticals In
|
Q3 2021
Filed on Nov 09, 2021
|
18,801,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
50
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
5,615,000
|
N/A
|
|
Tortoise Acquisition Corp Ii
|
Q3 2021
Filed on Nov 09, 2021
|
858,390
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
4,870,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
2,961,073
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
380
|
$60.18 - $64.39
$22.9K - $24.5K
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
588,287
|
N/A
|
|
Therapeutics Acquisition Cor
|
Q3 2021
Filed on Nov 09, 2021
|
1,494,816
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
2,440,000
|
N/A
|
|
|
Q3 2021
Filed on Nov 09, 2021
|
6,747,538
|
N/A
|
|